Global Intragastric Balloon Market accounted for US$ 14.2 million in 2020 and is estimated to be US$ 42.24 million by 2030 and is anticipated to register a CAGR of 11.5%. An intragastric balloon is a type of weight-loss procedure. A saline-filled or gas-filled silicone balloon is put in the stomach during this procedure, which aids weight loss by restricting the amount of food consumed. Since 1985, intragastric balloons have been used to treat obesity and to help people lose weight. For optimal results and the elimination of associated issues, many modifications and technological advancements have been made. Since 1985, various intragastric balloons have been authorised for sale in Europe and South America. However, due to a variety of adverse effects and problems, the US FDA did not approve any additional devices until 2015.